Speakers from 2013...
Marilyn Allison has spent the last 4 years as part of the Quality and Regulatory Affairs group at CareFusion. Over the past two years, she has led a CareFusion strategy team to create a holistic approach to meeting the multiple regulatory, customer, and business initiatives driving global standards adoption. Prior to joining CareFusion, Marilyn spent 10 years as a technical writer and documentation manager, and 10 years teaching writing and literature at the college level. Marilyn holds a Ph.D. in English Literature from Vanderbilt University. In her free time, she enjoys spending time with her family, reading, and learning to play the cello.
Prof. Amatucci received his Doctoral ('95) degree from Rutgers University. From 1991-2003 his research was focused on the study of lithium based electroactive materials and non-aqueous energy storage devices in collaboration with and later as an employee of Bellcore - Telcordia Technologies' Energy Storage Research Group located in Red Bank, New Jersey. Glenn was the Director of Energy Storage Research at Telcordia from 1998-2003. He joined Rutgers University and is currently a Professor of Materials Science and Engineering and a member of the Graduate Faculty of Biomedical Engineering. Glenn has authored or co-authored over 100 refereed papers, 2 book chapters, and has been granted 23 U.S. patents and multiple international, one of which resulting in an R&D Magazine top 100 technologies. His current research focus is on the enabling of new energy storage and chemistries and devices through the use of novel nanocomposite electroactive materials to address the extremes of the power/energy spectrum. His ESRG laboratories perform basic electroactive nanomaterial research to proof of concept prototype device fabrication in a specialized laboratory facility located at the Technology Center of New Jersey.
Arthur Calick MD, FACC, FACP, FSCAI, FAHA has been the Chairman of the Chest Pain Center at Fountain Valley Regional Hospital since 2007. He is also an expert reviewer on the Medical Board of California, Cardiology. Arthur has been a Board Certified Interventional Cardiologist since 2000 and received the Best Doctor Award (Cardiology) in 2011 and 2012 from US News & World Report. Arthur also currently runs his own private practice cardiology in Huntington Beach, California. He was also Clinical Professor at the University California Irvine, Department of Internal Medicine.
Michael Cao, Cardiologist, Keck Hospital of USC
Michael Cao, MD is an Assistant Professor of Medicine at the USC Keck School of Medicine, specializing in the diagnosis and treatment of arrhythmias. Currently, Dr. Cao is the Director of Cardiac Electrophysiology Laboratory, Associate Medical Director of Cardiac Research, Director of the Stress Testing Laboratory, and Director of the EKG Laboratory at LA County/USC Medical Center and previously was the Chief of Cardiology, Director of Cardiac Catheterization Laboratory, and Director of the Pacemaker/Internal Cardiac Defibrillator (ICD) Services at David Grant Medical Center. At LA County/USC Medical Center, Dr. Cao has actively been involved in state of the art research. In addition, Dr. Cao is considered an expert on cardiac medical devices and arrhythmias where he has been an invited presenter both nationally and internationally.
Stacey Chang is an Associate Partner at IDEO and directs IDEO's Healthcare practice. Working across several IDEO offices since 1995, he has led efforts creating new offerings in healthcare therapies and services, products and devices, research, and market strategy targeting healthcare professionals and consumers alike. Clients within the healthcare industry range from healthcare delivery institutions to major pharmaceutical and device manufacturers and medical technology start-ups. In his current role at IDEO, his responsibility centers on helping clients understand their unique contribution to the broader healthcare ecosystem and helping them develop breakthrough offerings that are as beneficial for their end users as they are for their bottom lines.
In addition to his work at IDEO, Stacey has founded financial services software companies, led instrument platform development for surgical robotic systems, and counts among his experience forays into automotive design, corporate research and academic teaching. He also actively mentors several technology start-ups in Silicon Valley. In all his engagements, Stacey is passionate about the application of design thinking and developing technology towards the betterment of the human condition.
Stacey was named to Medical Device and Diagnostics Industry magazine's "40 under 40" list of medical technology innovators in 2012. He holds an MS from Stanford University and a BS from the Massachusetts Institute of Technology.
Crystal Cunanan is the Director of Tissue Engineering at Boston Scientific-Sadra Medical and has over 25 years of experience developing and qualifying Class III devices made from polymers and biologics. Working in large companies, start-ups and consulting, she is skilled at both R&D and scaling up processes to meet production demands within scientific principles to ensure consistent product performance. She is a former Chair of BEMA and elected AIMBE fellow, 2007. She has over 40 US patents and published applications and numerous peer-reviewed publications and invited book chapters. She has an M.S. in Chemistry from UC San Diego.
Mart Eenink obtained his PhD in The Netherlands in the area of resorbable polymers for drug delivery applications. Since 20 years, he is now working at Purac in The Netherlands and is currently the Director of Global Sales Biomaterials.
Purac Biomaterials is a leading supplier of resorbable polymers based on lactide, glycolide and caprolactone monomers as raw materials worldwide to a wide range of medical device and pharmaceutical applications. Applications areas include resorbable sutures, orthopedic fixation implants, drug delivery systems, cardiovascular devices and various others.
Alex Fay manages business development efforts targeted at clean transportation applications and oversees research and development programs at Quallion, a manufacturer of lithium ion batteries for medical, military, aerospace, and transportation applications.
Alex's portfolio includes Quallion's work with the US Advanced Battery Consortium, a partnership of US automakers and the Department of Energy to advance electric vehicle technologies, and the company's effort to expand its manufacturing capabilities through a grant from the California Energy Commission. He also works closely with Quallion's R&D and engineering teams to develop novel lithium ion battery chemistries, cell designs, and safety features.
Prior to joining Quallion, Alex worked as a clean technology advisor to Los Angeles Mayor Antonio Villaraigosa. Alex is a graduate of UCLA.
Dan has over 11 years of experience developing a wide range of manufacturing processes and custom automated equipment and 9 years of experience designing implantable medical devices and components. Prior to joining Boston Scientific, Dan worked for 3M's Microelectronic Products Division and W.L. Gore and Associates. At Boston Scientific, Dan has pioneered the development of many new manufacturing processes, test methods, materials, medical devices, and device packages.
Ken is a Sr. Principal Architect in the Technical Research Institute at Mindray North America in Mahwah, New Jersey. His focus is on connecting Mindray's patient monitoring, anesthesia and other product lines to one another and to the enterprise as well as investigating new business and research opportunities. Ken holds Bachelor and Masters Degrees in Engineering from Rensselaer Polytechnic Institute (Troy NY) as well as an MBA from Babson College (Wellesley Hills MA).
Ken is active in standards development related to medical device connectivity and interoperability. In addition to his work as past co-chair of the Integrating the Healthcare Enterprise Patient Care Device (IHE PCD) Domain Planning Committee, he is secretary of the IEEE 11073 working group and also participates in AAMI, IEEE ASTM F29 ICE and IEC 80001 standardization efforts.
Nikhil is the Chief Engineer at Mobisante a pioneer in the field of mobile health. Mobisante built the worlds first cellphone based ultrasound machine, was also the first mobile application to be cleared by the FDA and has won numerous national and international awards including being voted the most innovative mHealth company in 2011 by the GSMA.
Nikhil has over a decade of experience working on cloud, mobile and enterprise products for Microsoft, Nokia and at his own startup. Nikhil has a Masters Degree from the School of Computer Science at Carnegie Mellon and an undergraduate degree in electrical engineering from the university of Mumbai. Nikhil's passion is bringing to market innovative new products that leverage software, hardware and the cloud.
Dr. Hunter received degrees from Caltech (B.S., Engineering), Georgia Tech (M.S., Mechanical Engineering; Ph.D., Bioengineering), and Grace College (M.A., Orthopaedic Regulatory and Clinical Affairs). Upon completing his Ph.D., he spent two years as a post-doctoral fellow at the University of Calgary, followed by seven years as faculty in the Centre for Bioengineering Research & Education at the University of Calgary. His specialty areas include cartilage and intervertebral disc biology, tissue engineering, and biomechanics.
In 2010, he decided it was time for a change. Zimmer, Inc. is the world's largest 'pure play' orthopaedics firm and a global leader in orthopaedic implant development. The External Research program at Zimmer provides financial and material support for research projects that align with the company's strategic and business interests. Thus the position of Manager, External Research offered Dr. Hunter an opportunity to utilize his background in academic research while learning the unique aspects of industry.
When not at work, Dr. Hunter studies Bujinkan Budo Taijutsu (currently 6th Kyu), is an avid runner and cyclist, dabbles with amateur photography, and trains his field-bred English Cocker Spaniel.
Dennis D. Jamiolkowski, Distinguished Research Fellow at ETHICON, Inc. a Johnson & Johnson Company, has over 38 years of experience with absorbable polymers. This includes synthesis of new monomers for absorbable polymers, new absorbable polymers, absorbable polymer processing, and mechanical design innovations. He has a degree in Chemistry (Honors) from Seton Hall University and has done post-graduate work at Polytechnic University (Brooklyn, NY). He is a named inventor on 88 issued United States patents, and has contributed over 40 articles, including chapters in eight books, to the open technical literature. He has been a speaker at academic institutions and society meetings; he was an invited keynote speaker at the 7th World Biomaterials Congress. Dennis has been a contributor to the development of medical devices made from absorbable polymers that have enjoyed a great deal of commercial success. The most recent of these is the ETHICON SECURESTRAP™ 5mm Absorbable Strap Fixation Device, used for mesh fixation in endoscopic procedures. Dennis has received J&J's Philip B. Hofmann Research Scientist Award an unprecedented four times. He additionally received Johnson and Johnson's highest honor for research and development, the prestigious Johnson Medal.
Dr. Jennings is Founder and CSO of Ariste Medical, Inc, a medical device company that transforms ePTFE and other material implants into drug delivery devices via a controlled drug elution technology. She is also a tenured Professor of Medicine and Director of Vascular Biology at the University of Tennessee Health Science Center (UTCHS) in Memphis, Tennessee. Dr. Jennings has secondary appointments at the rank of Professor in the Departments of Molecular Sciences and Surgery as well as in the Joint Program of Biomedical Engineering at UTHSC and the University of Memphis. She has more than 100 articles in peer-reviewed journals and 125 abstracts. She has received continuous grant support by the NIH, the American Heart Association and industry since 1983. Dr. Jennings serves as a member of advisory boards for pharmaceutical and biotechnology companies and is a KOL in the area of anti-thrombotic therapies and cardiovascular disease.
Derek Mortisen, Senior Scientist at Abbott Vascular, has over ten years of experience working with bioresorbable polymers. As a graduate student at the University of Washington in Buddy Ratner's lab, Derek designed biodegradable hydrogels for cardiac tissue engineering. As a post doctoral fellow at the AO Foundation in Davos, Switzerland, Derek worked with Mauro Alini on a project to develop thermoreversible hyaluronic acid hydrogels for drug delivery and cell encapsulation. Derek is currently working with Abbott Vascular on the Absorb™ Bioresorbable Vascular Scaffold.
Jim has 30 years' experience in the medical device industry, with 25 years' experience in product management, international sales and executive marketing management. He has held senior management positions for start-ups and high tech medical companies since 1992. He has worked on the development of several medical devices such as biochemistry analyzers, ophthalmic surgical systems, operating microscopes, lasers, micro-endoscopes, neuro-stimulators and biosensors.
Mark Phelps has over 25 years experience in the design and development of high technology and high reliability products for medical, automotive, and defense industries. He recently rejoined Medtronic, the world's leading medical technology company, where he runs pro-grams for miniature implantable diagnostics and monitoring devices in Minneapolis, Minne-sota. He previously spent 10 years at the Medtronic Microelectronics center in Tempe, Arizona developing implantable electronic modules and miniaturized system technology.
Prior to this, Dr. Phelps led the Engineering team for TASER International including on-body wireless video systems to provide evidence capture, storage, search, and review in Scottsdale, Arizona. He joined TASER after establishing a research and development center for wireless transmission of vital signs with disposable sensors for LifeSync Corporation in Atlanta, Georgia. He also worked at Motorola Sensor Product Division on MEMs acceleration sensors for automobiles in Phoenix, Arizona. Prior to that, he led the engineering lab for Texas In-strument's infrared night vision systems for the Defense Systems and Electronics Group in Dallas, Texas.
Dr. Phelps has a PhD in Electrical Engineering from Florida Institute of Technology in Mel-bourne, Florida.
Phil Raymond is a 21 year veteran in the wireless connectivity industry and is currently the Wireless Architect & Network Product Manager in Philips Healthcare Patient Monitoring Systems. Phil is a long time member of IEEE focused on data communications and RF design and currently serves as the chair of the Wi-Fi Alliance Healthcare Task Group. Phil continues his involvement in the standards development space including IEC/ISO 80001-1, and served as the co-chair for the IEC/ISO 80001-2-3 Wireless Guidance Technical Report team. Phil received his bachelor of electrical engineering from Georgia Tech.
Dr. Arya Nick Shamie is a Board Certified Spine Surgeon and Associate Professor of Orthopedic Surgery and Neurosurgery at UCLA. He has served on the UCLA School of Medicine Faculty since 2000. He is the current President of the American College of Spine Surgery. Dr. Shamie is also actively involved in graduate and medical education, offering his expertise to help educate medical students, residents and fellows in training. Additionally, he is a significant contributor in scientific and clinical research involving spine surgery. Dr. Shamie was the recipient of the UCI School of Medicine Award for Excellence in Research. He has received recognitions from several prominent organizations, including: Castle Connonlly's Top Doctors of Southern California, America's Most Compassionate Doctors, SRS Dawson Traveling Fellowship, and Becker's Orthopedic & Spine Review listing of the top 10 medical center spine surgeons. He was also selected as the Expert Reviewer for the Medical Board of California in 2012 and is a Qualified Medical Evaluator for the State of California.
Dr. Shamie received his medical degree at Northwestern University Feinburg School of Medicine. He completed his residency at St. Mary's Medical Center, and his internship at LAC and USC Medical Centers. He has acquired fellowship at the UCLA School of Medicine for both Spine Surgery and Bone Research. He provides his consulting services at the Ronald Reagan UCLA Medical Center, as well as, UCLA's Medical Center in Santa Monica.
Dr. Miranda N. Shaw is a Senior Research Engineer in the Advanced Technology Group at Zimmer, Inc., Warsaw, Indiana. As part of a cross-disciplinary team, she identifies unmet and unarticulated clinical needs, develops and explores advanced technologies, and commercializes novel solutions for the musculoskeletal industry. She is currently leading the development of disruptive soft tissue technologies and strategic planning. Prior to joining Zimmer, Dr. Shaw was the co-founder and managing partner of Innovaject LLC, Columbia, Missouri. An early stage product development and licensing company, Innovaject developed a proprietary, innovative delivery mechanism for the prevention and therapeutic treatment of mastitis in dairy animals. Medical device innovation, orthopedic implant design, spine biomechanics, and orthopedic computational biomechanics are among Dr. Shaw's current research interests. She has published numerous peer reviewed articles, abstracts, and international presentations and holds pending patents. Dr. Shaw received a Bachelor of Science in Mechanical Engineering from Ohio Northern University, Master of Science in Bioengineering from the University of Toledo, and a Doctor of Philosophy degree from the Mayo Graduate School, Mayo Clinic. She completed a post-doctoral fellowship as the Entrepreneurial Engineering Fellow in the Biodesign and Innovation Program at the University of Missouri.
Andrew I. Spitzer, MD is an orthopedic surgeon and Director of the Joint Replacement Program at the Cedars-Sinai Orthopaedic Center. He also is a member of the Cedars-Sinai/USC School of Theatre Dance Medicine Center.
Dr. Spitzer's primary medical and research interests include hip and knee replacement surgery and implant design, orthopedic surgery, blood management in total joint replacement, prevention of postoperative thromboembolic disease (blood clots), and the non-operative management of osteoarthritis of the hip and knee.
Dr. Spitzer is board certified by the American Board of Orthopaedic Surgery, and is a Fellow of the American Academy of Orthopedic Surgeons.
Dr. Spitzer has written numerous articles for peer-reviewed publications and contributed chapters to textbooks on hip and knee replacement. He has lectured extensively and presented scientific papers throughout the United States and around the world. He also serves as a consultant reviewer to many of the major orthopedic journals, including the Journal of Bone and Joint Surgery and Clinical Orthopaedics and Related Research.
Dr. Spitzer is a member of the American Association of Hip and Knee Surgeons, Western Orthopaedic Association, California Orthopaedic Association, Los Angeles Academy of Medicine and American Academy of Orthopaedic Surgeons.
Dr. Spitzer earned his bachelor's degree from Columbia University and his medical degree from the University of California, Los Angeles School of Medicine. He completed an internship in general surgery and a residency in orthopedic surgery at the Hospital of the University of Pennsylvania. He completed a postdoctoral research fellowship at McKay Laboratories for Orthopaedic Surgery Research at the University of Pennsylvania School of Medicine and a surgical fellowship in joint replacement surgery at the Brigham and Women's Hospital, Harvard Medical School in Boston.
Jung-ik Suh has built 15 years' experience in wireless industry. Jung-ik began his career in Hewlett-Packard in 1997 as a technical support engineer partnering with base station developers. He also worked with major wireless players as sales account manager at Agilent and Skyworks solutions, respectively. In 2006, he joined the Agilent Asia marketing organization and led various wireless marketing initiatives as Asia wireless program manager. From 2010, Jung-ik has worked for worldwide marketing programs focusing on latest cellular and wireless connectivity technologies including 3G, LTE, LTE-Advanced, WLAN, Bluetooth, Zigbee, NFC and RFID in Agilent Electronic Measurement Group marketing organization. He has written various technical articles, created technical marketing materials, and delivered key notes speeches at major wireless events.
Scott Thiel, MBA, MT (ASCP), RAC, is Director of Connected Health Operations at Anson Group, where he assists clients in successfully commercializing wireless, mobile, and networked technologies in compliance with the rules and policies of the FDA and other regulatory agencies. Mr. Thiel has over 23 years of medical device
About Anson Group:
Dr. Robin Sarah Tichy has developed an expertise in translating market drivers into technical solutions in the battery and charger industry. Prior to joining Electrochem (formerly Micro Power Electronics, Inc.), she applied technical and project management skills to orchestrate and implement solutions to solve vital business problems at leading organizations like Hewlett Packard and International SEMATECH, in the semiconductor, nanotechnology and MEMS verticals. Dr. Tichy received a Doctor of Philosophy from the University of Texas for her work in Solid Oxide Fuel Cells.
Dr. Jose Fernandez Villasenor is Freescale's Medical Product Manager and Engineering Expert. He has a degree in Electronic Engineering from TEC de Monterrey University and a degree in Medicine and Surgery from Guadalajara's University in Mexico, with post-graduate studies in France and Japan. Dr. Fernandez is a practicing medical doctor, specializing in brain surgery.
Thomas J. Webster’s degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (M.S., 1997; Ph.D., 2000). He is currently the Department Chair of Chemical Engineering at Northeastern University in Boston. His research explores the use of nanotechnology in numerous applications. Specifically, his research addresses the design, synthesis, and evaluation of nanophase materials (that is, materials with fundamental length scales less than 100 nm) as more effective biomedical devices. He has completed extensive studies on the use of nanophase materials to regenerate tissues and has graduated/supervised over 109 visiting faculty, clinical fellows, post-doctoral students, and thesis completing B.S., M.S., and Ph.D. students. To date, his lab group has generated over 9 textbooks, 48 book chapters, 306 invited presentations, at least 403 peer-reviewed literature articles, at least 567 conference presentations, and 32 provisional or full patents. His H index is 45. Some of these patents led to the formation of 9 companies. His research on nanomedicine has received attention in recent media publications including MSNBC (October 10, 2005), NBC Nightly News (May 14, 2007), PBS DragonFly TV (covered across the US during the winter, 2008), and ABC Nightly News via the Ivanhoe Medical Breakthrough Segment (covered across the US during the winters of 2008 and separate research segments in 2010 and 2011). His work has been on display at the London and Boston Science Museums. He is the founding editor-in-chief of the International Journal of Nanomedicine (the first international journal in nanomedicine which in five years has achieved an impact factor of 4.97), serves on the editorial board of 15 additional journals, has helped to organize 22 conferences emphasizing nanotechnology in medicine, and has organized over 53 symposia at numerous conferences emphasizing biological interactions with nanomaterials. He also recently chaired the 2011 Annual Biomedical Engineering Society (BMES) Conference and has organized numerous symposia for AIChE, IEEE, MRS and ASME Annual Meetings. He has received numerous honors including, but not limited to: 2002, Biomedical Engineering Society Rita Schaffer Young Investigator Award; 2003, Outstanding Young Investigator Award Purdue University College of Engineering; 2005, American Association of Nanomedicine Young Investigator Award Finalist; 2005, Coulter Foundation Young Investigator Award; 2006, Fellow, American Association of Nanomedicine; 2010, Distinguished Lecturer in Nanomedicine, University of South Florida; 2011, Outstanding Leadership Award for the Biomedical Engineering Society (BMES); and Fellow, American Institute for Medical and Biological Engineering (AIMBE, representing the top 2% of all medical and biological engineers). He also currently serves as the Director of the Indo-U.S. Center for Biomaterials for Healthcare, which is an international collaboration between 20 universities/industries in India and the U.S. to foster biomaterial development.
Dr. Kevin White is a Managing Scientist in Exponent's Polymer Science and Materials Chemistry practice. His core discipline is electrochemistry, with extensive experience in electrochemical energy conversion, analytical chemistry, and materials science. Dr. White consults on a broad range of topics related to chemistry, materials, material processing, and failure analysis.
Dr. White addresses challenges related to battery technology, including battery-device relationships, battery material selection and testing, cell design and evaluation, performance degradation, and due diligence technology evaluation. His corrosion science practice includes material selection, processing, surface treatment and harsh environment corrosion. In addition, Dr. White consults on fuel cell electrochemistry including enzymatic and biologically based electrochemical conversion schemes.
Prior to joining Exponent, Dr. White was a Principal Research Scientist at Physical Sciences Inc. (PSI). As a member of the Materials Technology Group, his research and development efforts focused on novel architectures and materials for advanced lithium ion batteries, chemistry and coatings for corrosion inhibition in harsh environments and novel polymer processing techniques. His research yielded patents pending for a metal oxide/conducting polymer composite cathode system for lithium ion batteries and novel electrochemical energy device with power density characteristic of electrochemical capacitors and energy density characteristic of lithium ion batteries. In addition, Dr. White advanced anti-corrosion coatings for mild steel reinforcement in concrete for marine environments and the processing of polymers in functional, application driven nanoscale geometries.
Dr. White is a former NASA Fellow and is an active member of the Electrochemical Society serving as Chairman of the New England Section.
Rodney A. White, M.D. is Chief of Vascular Surgery and Associate Chairman of the Department of Surgery at Harbor-UCLA Medical Center, Torrance, California. He is also Director of the Vascular Surgery Residency programs at this institution. His academic appointment is Professor of Surgery, UCLA School of Medicine. He is certified by the American Board of Surgery with Special Qualifications In General Vascular Surgery and the by the American Board of Laser Surgery. He also has a permit as a Fluoroscopy Supervisor and Operator from the State of California, and is a Registered Vascular Technologist (RVT) certified by the American Registry of Diagnostic Medical Sonographers (ARDMS).
Dr. White's research interests include the development and evaluation of artificial implant materials, and laboratory and clinical investigation of fundamental problems and new procedures in peripheral vascular and general surgery. He is co-inventor of a process for fabricating microporous biomaterials including an artificial bone substitute that was recently awarded the first annual US Congressional Golden Goose Award for federally funded research that has lead to significant patient care and economic benefit. Current research programs involve the development and evaluation of endovascular surgical devices including atherectomy devices, stents, abdominal and thoracic endoluminal prostheses, and angioscopy and intraluminal ultrasound imaging technologies. Dr. White is the recipient of research grants from the National Institutes of Health, the American Heart Association and several corporations.
Dr. White is the author of more than 250 papers and book chapters, and is co-author or editor of twelve books addressing a broad spectrum of topics in vascular and endovascular surgery. He is a member of many industrial and governmental panels evaluating new medical technologies. He is past Vice-Chairman and currently a member-at-large of the Board of Directors of the Harbor-UCLA Research and Education Institute. Dr. White is an active member of 21 regional, national and international societies and is past- President of the International Society for Endovascular Specialists, and past Secretary of the Society for Vascular Surgery.
Gary Moscarello, Orthopedic Surgeon
Charles Swerdlow, Cardiac Electrophysiologies, Cedars-Sinai Medical Center; Ronald Reagan UCLA Medical Center